Liver Cancer News Banner

Welcome back to Liver Cancers News – where we keep you up-to-date on what’s happening in the liver cancer world.


Vote for GLI for a Healio Disruptive Innovators Award


Great news! Healio named GLI CEO Donna Cryer a nominee for its Disruptive Innovators Award – Patient Voice. We are grateful for the recognition of her leadership in advancing research and problem-solving in liver disease and equipping other advocates!

🗳 Vote for Donna and other disruptive innovators today!

A3: The Learning Experience

will be held in Washington DC from September 30 – October 2, 2023!


If you are a liver patient, caregiver, family member, or clinician searching for an opportunity to become an effective advocate through interactive lessons on how to share your story, understand recent research & development, how to leverage social media and more.

✍🏼 Apply now

Essential Liver Patient Resource is Updated

The National Comprehensive Cancer Network (NCCN) has released their 2023 NCCN Guidelines For Patients: Liver Cancer in collaboration with GLI. This year’s Guidelines For Patients covers important topics in liver cancer such as liver cancer diagnosis, cancer staging, and how to make appropriate treatment decisions for patients and caregivers during the liver cancer journey.

A Stride to Improve Cancer Treatment

First Lady Jill Biden announced a proposal to have Medicare pay for principal illness navigation (PIN) services, which help cancer patients make choices for their treatment plans and aid them in overcoming barriers in healthcare but can often be unaffordable. If the proposal passes, Medicare will begin covering the cost for navigation services beginning January 1, 2024, making navigation services more accessible to cancer patients.

Aspartame As A Possible Carcinogen


Aspartame, a sugar-free sweetener, has been widely used in food products for over forty years, including gum, diet soda, yogurt, ice cream, cereals, and even some medications. The World Health Organization, International Agency for Research on Cancer, and the Food and Agriculture Organization Joint Expert Committee on Food Additives has found limited evidence to classify aspartame as a potential carcinogen in humans, specifically for hepatocellular carcinoma. Still, the somewhat controversial assessment reaffirmed the existing, safe threshold of aspartame consumption as 0-40 mg/kg body weight.


Upcoming Events:


It’s not only important to GLI to keep you updated; we value your input and updates. This is a reminder to Liver Cancers Council members and supporters to share news to be featured in our monthly newsletter or on our Liver Central website.

For more information about the Liver Cancers Council or to learn more about joining, please visit or email